HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura.

Abstract
Treatment with 75 microg/kg/d intravenous (i.v.) anti-D was compared with 50 microg/kg/d in a prospective randomized study of 27 RhD-positive, human immunodeficiency virus-negative, adult, acute, non-splenectomized patients with immune thrombocytopenic purpura (ITP) and platelet counts < or = 30 x 109/l. The higher dose resulted in greater median d 1 (43 x 109/l vs. 7.5 x 109/l; P = 0.012) and d 7 (153 x 109/l vs. 64.5 x 109/l; P = 0.001) platelet increases despite no greater haemoglobin decrease. Children with acute ITP receiving 75 microg/kg/d had overnight platelet increases in seven out of nine cases. The duration of effect at the 75 microg/kg/d dose was 46 d vs. 21 d (P = 0.03). Adverse events were mild to moderate and ameliorated with prednisone and acetaminophen premedication.
AuthorsG C Newman, M V Novoa, E M Fodero, M L Lesser, B M Woloski, J B Bussel
JournalBritish journal of haematology (Br J Haematol) Vol. 112 Issue 4 Pg. 1076-8 (Mar 2001) ISSN: 0007-1048 [Print] England
PMID11298610 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents
  • Rho(D) Immune Globulin
  • Acetaminophen
  • Prednisone
Topics
  • Acetaminophen (therapeutic use)
  • Adult
  • Analgesics, Non-Narcotic (therapeutic use)
  • Anti-Inflammatory Agents (therapeutic use)
  • Child
  • Drug Administration Schedule
  • Humans
  • Infusions, Intravenous
  • Platelet Count
  • Prednisone (therapeutic use)
  • Premedication
  • Prospective Studies
  • Purpura, Thrombocytopenic (blood, therapy)
  • Rho(D) Immune Globulin (administration & dosage)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: